P03375 (ENV_HV1B1) Human immunodeficiency virus type 1 group M subtype B (isolate BH10)(HIV-1)
Envelope glycoprotein gp160 UniProtKBInterProInteractive Modelling
856 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
7 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Structure of HIV-1 gp41 NHR/fusion inhibitor complex P21 |
Heteromer | 1×MG; | ||||
Assess | ||||||
Structure of HIV-1 gp41 NHR/fusion inhibitor complex P321 |
Heteromer | 3×SO4; | ||||
Assess | ||||||
Potent HIV fusion inhibitor CP32M-2 |
Heteromer | |||||
Assess | ||||||
Short peptide HIV entry Inhibitor SC22EK |
Heteromer | 3×SO4; 3×NH4; | ||||
Assess | ||||||
Short peptide HIV entry inhibitor MT-SC22EK with a M-T hook |
Heteromer | 3×SO4; | ||||
Assess | ||||||
Crystal structure of the clade B isolate B41 mutant fusion peptide (residues 512-521) in complex wi… |
Heteromer | |||||
Assess | ||||||
Solution structure of micelle-bound fusion domain of HIV-1 gp41 | monomer | |||||
Assess |
2 SWISS-MODEL models
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
8eu8.1.A | homo-3-mer | 0.66 | 3×NAG; | 75.65 | ||
Assess | ||||||
7n6u.1.A | homo-3-mer | 0.56 | 2×NAG; 2×NAG; 3×83G; | 89.96 | ||
Assess |